| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-10 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |